SYNDESI THERAPEUTICS

syndesi-therapeutics-logo

Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the brain). Regulating synaptic transmission represents a promising approach to treating Alzheimerโ€™s Disease and other disorders with cognitive impairment. Syndesi has an exclusive license to its platform technology from UCB, the leading company in SV2A research.

#People #Financial #Website #More

SYNDESI THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2018-01-01

Address:
Louvain-la-neuve, Vlaams-Brabant, Belgium

Country:
Belgium

Website Url:
http://www.syndesitherapeutics.com

Total Employee:
11+

Status:
Closed

Contact:
+32 10 280 238

Email Addresses:
[email protected]

Total Funding:
26.2 M EUR

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator



Current Advisors List

morten-graugaard-dรธssing_image

Morten Graugaard Dรธssing Member Board Of Directors @ Syndesi Therapeutics
Board_member
2018-02-01

christina-takke_image

Christina Takke Member of the Board @ Syndesi Therapeutics
Board_member
2017-12-01

Current Employees Featured

jean-combalbert_image

Jean Combalbert
Jean Combalbert Non Executive Chairman @ Syndesi Therapeutics
Non Executive Chairman
2018-04-01

not_available_image

Jonathan Savidge
Jonathan Savidge CEO @ Syndesi Therapeutics
CEO
2018-02-01

torsten-m-madsen_image

Torsten M. Madsen
Torsten M. Madsen Chief Medical Officer @ Syndesi Therapeutics
Chief Medical Officer
2019-11-01

Founder


not_available_image

Jonathan Savidge

Investors List

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series A - Syndesi Therapeutics

fountain-healthcare-partners_image

Fountain Healthcare Partners

Fountain Healthcare Partners investment in Series A - Syndesi Therapeutics

v-bio-ventures_image

V-Bio Ventures

V-Bio Ventures investment in Series A - Syndesi Therapeutics

johnson-johnson-innovation-jjdc_image

Johnson & Johnson Innovation โ€“ JJDC

Johnson & Johnson Innovation โ€“ JJDC investment in Series A - Syndesi Therapeutics

ucb-ventures_image

UCB Ventures

UCB Ventures investment in Series A - Syndesi Therapeutics

s-r-i-w_image

S.R.I.W.

S.R.I.W. investment in Series A - Syndesi Therapeutics

vives-fund_image

Vives Louvain Technology Fund

Vives Louvain Technology Fund investment in Series A - Syndesi Therapeutics

w-in-g_image

W.IN.G

W.IN.G investment in Grant - Syndesi Therapeutics

vives-fund_image

Vives Louvain Technology Fund

Vives Louvain Technology Fund investment in Series A - Syndesi Therapeutics

fountain-healthcare-partners_image

Fountain Healthcare Partners

Fountain Healthcare Partners investment in Series A - Syndesi Therapeutics

Official Site Inspections

http://www.syndesitherapeutics.com

  • Host name: 159.180.132.176
  • IP address: 159.180.132.176
  • Location: North Chicago United States
  • Latitude: 42.325
  • Longitude: -87.8561
  • Metro Code: 602
  • Timezone: America/Chicago
  • Postal: 60064

Loading ...

More informations about "Syndesi Therapeutics" on Search Engine